Data as of Jan 29
| +1.28 / +1.87%|
The 11 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 68.00, with a high estimate of 81.00 and a low estimate of 10.00. The median estimate represents a -2.66% decrease from the last price of 69.86.
The current consensus among 12 polled investment analysts is to Buy stock in Isis Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.